Calcium D3 Nycomed tab Gesves. 120 pcs orange

$11.36

Calcium D3 Nycomed tab Gesves. 120 pcs orange

Quantity:

SKU: 2032599611 Categories: , , Tag:

Description

Composition
Active substance:
1 tablet contains: Calcium carbonate – 1250 mg (equivalent to elemental calcium – 500 mg) Kolekaltsiferol (vitamin D3) – 5,0 mcg (200 IU) as a concentrate kolekaltsiferola – 2.0 mg.
Excipients:
Sorbitol – 390 mg, povidone – 36.4 mg magnesium stearate – 6.00 mg Aspartame – 1.00 mg of orange flavoring granules – 63.0 mg or mint flavoring granules -31.8 mg or strawberry flavor granulate watermelon – 10.2 mg.
Description:
Chewable Tablets (orange)
Round biconvex white with orange flavor. May have slight yellow blotches and uneven edges.
Chewable Tablets (peppermint)
Round biconvex white with mint aroma. Can have small inclusions from white to grayish color and irregular edges.
Chewable tablets (strawberry, watermelon)
Round biconvex white with strawberry-watermelon flavor. Can have small inclusions from yellow to grayish color and irregular edges.
Product form:
Chewable Tablets (orange), 500 mg plus 200 IU. 20, 30, 50, 60, 100 or 120 tablets in a bottle of high-density polyethylene, a sealed screw cap, under which there is a tear ring gasket which provides the first control opening. 1 vial together with instructions for use placed in a pile of cardboard.
Chewable Tablets (mint), 500 mg + 200 IU. 30, 60, 100 or 120 tablets in a bottle of high-density polyethylene, a sealed screw cap, under which there is a tear ring gasket which provides the first control opening. 1 vial together with instructions for use placed in a pile of cardboard.
Chewable tablets (strawberry, watermelon), 500 mg + 200 IU. 30, 60, 90 or 120 tablets in a bottle of high-density polyethylene, a sealed screw cap, under which there is a tear ring gasket which provides the first control opening. 1 vial together with instructions for use placed in a pile of cardboard.
Contraindications
Hypercalcemia (increased calcium concentration in blood). Hypercalciuria (high urinary calcium). Nephrolithiasis. Hypervitaminosis D. Increased sensitivity to the drug. Hypersensitivity to soya or peanut. Severe renal insufficiency. Active tuberculosis.
The drug in the dosage form of a tablet is not used in children under the age of 3 years. Calcium-D3 Nycomed comprises aspartame, which in the body is transformed to phenylalanine. Therefore, the drug should not be taken by patients with phenylketonuria. Chewable Tablets (orange, mint) contain sorbitol, isomalt and sucrose. Chewable tablets (strawberry, watermelon) comprise sorbitol and sucrose. The use is not recommended for patients with hereditary fructose intolerance, glucose-galactose malabsorption or sucrase-insufficiency izomaltaznoy.
Carefully
Pregnancy, lactation, renal failure. Calcium carbonate kolekaltsiferola should be used with caution in patients with sarcoidosis, due to risk of increased metabolism of vitamin D3 to its active form. In these patients, it is necessary to control the concentration of calcium in the blood serum and urine.
Dosage
500 mg + 200 IU
Indications
Prevention and treatment of calcium deficiency and / or vitamin D3.
Addition to specific treatment and prevention of osteoporosis and its complications (fractures).
Interaction with other drugs
Hypercalcemia may potentiate toxic effects of cardiac glycosides while the use of calcium and vitamin D. electrocardiogram is necessary to control and the calcium content in serum. Calcium can reduce the absorption of tetracyclines from the gastrointestinal tract. Therefore, drugs of tetracycline should take no less than 2 hours before or within 4-6 hours after ingestion of Calcium-D3 Nycomed. To prevent absorption of drugs bisphosphonates decrease their recommended to take at least one hour before a Calcium-D3 Nycomed. Glucocorticosteroids reduce calcium absorption, so glucocorticosteroid may require increasing doses of Calcium-D3 Nycomed. With simultaneous use of thiazide diuretics series increases the risk of hypercalcemia, since they increase the tubular reabsorption of calcium. With simultaneous use of thiazide diuretics should be regular monitoring of serum calcium. Calcium reduces the effectiveness of levothyroxine decrease its absorption. The period of time between doses of levothyroxine and Calcium-D3 Nycomed should be at least 4 hours. Suction quinolone antibiotics group, while the application is reduced with calcium supplementation. Therefore, quinolone antibiotics group should be taken 2 hours before or 6 hours after ingestion of Calcium-D3 Nycomed. Calcium salts may reduce the absorption of iron, zinc and strontium ranelate. Therefore, iron preparations, zinc or strontium ranelate should take at least two hours before or two hours after receiving Calcium – D3 Nycomed. Orlistat treatment could potentially interfere with the absorption of fat-soluble vitamins (e.g., vitamin D3).
Overdose
Overdose can lead to hypervitaminosis and hypercalcaemia D. Overdose symptoms (hypercalcemia): anorexia, thirst, polyuria, muscle weakness, nausea, vomiting, constipation, abdominal pain, fatigue, bone pain, mental disorders, polydipsia, nephrocalcinosis, urolithiasis and, in severe cases, cardiac arrhythmias. Prolonged use of excessive doses (over 2500 mg calcium) – kidney damage, calcification of soft tissues. Milk-alkali syndrome (Burnett syndrome) may occur in patients with ingestion of large amounts of calcium and alkaline solutions is well absorbed. In the event of overdosage symptoms is necessary to stop taking calcium and vitamin D3, as well as the thiazide diuretics, and cardiac glycosides, and to consult a doctor. Treatment: gastric lavage, replenishment of fluid loss, the use of loop diuretics (e.g., furosemide), glucocorticoids, calcitonin, bisphosphonates. It is necessary to control the content of electrolytes in the blood plasma, kidney function and urine output. In severe cases, the necessary measurement of central venous pressure (CVP) monitoring and electrocardiogram (ECG).
pharmachologic effect
Pharmacological group:
Calcium-phosphorus metabolism regulator.
Pharmacodynamics:
A combined preparation, which regulates the exchange of calcium and phosphorus in the body (bones, teeth, nails, hair, muscles). Decreases resorption (resorption) and increases bone density, filling the lack of calcium and vitamin D3 in the body is required for mineralization of teeth. Calcium is involved in the regulation of nerve conduction, muscle contraction, hormone and is a component of the blood coagulation system. Adequate calcium intake is particularly important in a period of growth, pregnancy and lactation. Vitamin D3 increases calcium absorption in the intestine. The use of calcium and vitamin D3 prevents the increase in the production of parathyroid hormone (PTH), which is a stimulator of increased bone resorption (leaching calcium from the bones).
Pharmacokinetics:
Calcium
Absorption: calcium usually sucked into the gastrointestinal tract is about 30% of the dose.
Distribution and metabolism: 99% of the calcium in the body is concentrated in the rigid structure of bones and teeth. The remaining 1% is in the intra- and extracellular fluids. About 50% of the total blood calcium content is in the physiologically active ionised form, of which about 10% in combination with citrate, phosphate, or other anions, the remaining 40% bound to protein, primarily albumin.
Excretion: calcium derived intestines, the kidneys and sweat glands. Renal excretion depends on glomerular filtration and tubular reabsorption of calcium.
vitamin D3
Absorption: Vitamin D3 is readily absorbed in the small intestine (about 80% of the dose).
Distribution and metabolism: Kolekaltsiferol and its metabolites circulate in the blood associated with a specific globulin. Kolekaltsiferol converted in the liver by hydroxylation to 25-gidroksikolekaltsiferola. Then converted in the kidneys to the active form 1,25-gidroksikolekaltsiferol. 1.25 gidroksikolekaltsiferol metabolite is responsible for increasing calcium absorption. Unmetabolized vitamin D3 is deposited in fat and muscle tissue.
Excretion: Vitamin D3 is derived intestines and kidneys.
Pregnancy and breast-feeding
Calcium-D3 Nycomed used during pregnancy to replenish the calcium and vitamin D3 deficiency in the body. The total daily intake during pregnancy should not exceed 2500 mg calcium and 4000 IU vitamin D. Hypercalcemia amid overdose during pregnancy may have adverse effects on the developing fetus. Calcium D3 Nycomed is used during lactation. Calcium and vitamin D3 can penetrate into breast milk, so you need to take into account the intake of calcium and vitamin D from other sources in the mother and child.
Conditions of supply of pharmacies
Without a prescription.
side effects
The incidence of side effects of the drug is considered as follows:
Very common:> 1/10
Common:> 1/100, 1/1000,
special instructions
When long-term therapy should be monitored calcium and creatinine in serum. The observation is especially important in elderly patients with simultaneous treatment with diuretics and cardiac glycosides (see. See “The interaction with other drugs and food”), and in patients with an increased tendency to form kidney stones. In case of hypercalcaemia or signs of impaired renal function should reduce the dose or stop treatment. Vitamin D3 should be used with caution in patients with renal insufficiency. In this case it is necessary to control the content of calcium and phosphate in the serum. It is also necessary to take into account the risk of soft tissue calcification. To avoid overdose, it is necessary to take into account the additional intake of vitamin D and calcium from other sources. Calcium and vitamin D3 should be used with caution in immobilized patients with osteoporosis due to the risk of hypercalcemia. The simultaneous use of antibiotics tetracycline or quinolone is usually not recommended or should be done with caution (see. See “The interaction with other drugs and food”).
Effect on the ability to drive mechanisms and
There are no data regarding the effects of the drug Calcium-D3 Nycomed on ability to drive and use machines.
Storage conditions
Keep the vial tightly closed at a temperature not higher than 25 C.
Keep out of the reach of children!.
Dosing and Administration
Calcium D3 Nycomed is taken orally. The tablets can be chewed or dissolve and take into mealtime.
Prevention and treatment of calcium deficiency and / or vitamin D3.
Adults and children over 12 years – 1 tablet 2 times a day, or 2 tablets once a day. Children from 5 years to 12 years – 1-2 tablets a day. Children from 3 to 5 years – the dosage recommended by your doctor.
Addition to specific treatment and prevention of osteoporosis and its complications (fractures). Adults – 1 tablet 2-3 times a day.
Special patient groups
Patients with hepatic impairment:
No dose adjustment is required
Patients with impaired renal function:
You should not use the drug Calcium-D3 Nycomed in severe renal insufficiency
Elderly patients: The dose is the same as for adults. It should take into account a possible reduction in creatinine clearance.
duration of treatment
When used in the prevention and treatment of calcium deficiency and / or vitamin D3 average duration of treatment not less than 4-6 weeks. The number of repeated courses is determined individually during the year. When applying for a supplement to specific treatment and prevention of osteoporosis and its complications (fractures) the duration of treatment is determined individually by the physician.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

Calcium D3 Nycomed

There are no reviews yet.

Add your review